Gili Regev-Yochay

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 19

Top Venues

Nature communications

The New England journal of medicine

Epidemiology and infection

Vaccines

Sheba Medical Center

Harvard School of Public Health (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sheba Medical Center Jan 01 2017

Israel

Director :: Infection Prevention & Control Unit

Education History

Harvard School of Public Health Sep 01 2006 - Jun 30 2008

United States

MSC :: Epidemiology

Weizmann Institute of Science Sep 01 1990 - Jun 30 1991

Israel

MSC :: Neurobiology

Publications

Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 14 (1) (2023)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 14 (1) (2023)
Gili Joseph, Carmit Cohen, Carmit Rubin, Havi Murad, Victoria Indenbaum, Keren Asraf, Yael Weiss-Ottolenghi, Gabriella Segal-Lieberman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Humoral Immunity of Unvaccinated COVID-19 Recovered vs. Naïve BNT162b2 Vaccinated Individuals: A Prospective Longitudinal Study. Microorganisms 11 (7) (2023)
Stephen Moss, Menucha Jurkowicz, Ital Nemet, Nofar Atari, Limor Kliker, Bayan Abd-Elkader, Tal Gonen, Emily Toth Martin, Yaniv Lustig, Gili Regev-Yochay, Michal Mandelboim
Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter Season. Vaccines 11 (10) (2023)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 13 (1) (2022)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 13 (1) (2022)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 13 (1) (2022)
Yaniv Lustig, Tal Gonen, Lilac Meltzer, Mayan Gilboa, Victoria Indenbaum, Carmit Cohen, Sharon Amit, Hanaa Jaber, Ram Doolman, Keren Asraf, Carmit Rubin, Ronen Fluss, Ella Mendelson, Laurence S Freedman, Gili Regev-Yochay, Yitshak Kreiss
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose. Nature immunology 23 (6) (2022)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 13 (1) (2022)
Gili Regev-Yochay, Tal Gonen, Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Sharon Amit, Lilac Meltzer, Keren Asraf, Carmit Cohen, Ronen Fluss, Asaf Biber, Ital Nemet, Limor Kliker, Gili Joseph, Ram Doolman, Ella Mendelson, Laurence S Freedman, Dror Harats, Yitshak Kreiss, Yaniv Lustig
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron. The New England journal of medicine 386 (14) (2022)
Gili Regev-Yochay, Or Kriger, Michael J Mina, Sharon Beni, Carmit Rubin, Bella Mechnik, Sabrina Hason, Elad Biber, Bian Nadaf, Yitshak Kreiss, Sharon Amit
Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings. Infection control and hospital epidemiology (2022)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 13 (1) (2022)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Tal Gonen, Keren Asraf, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Dror Harats, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up. Nature communications 13 (1) (2022)
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Keren Asraf, Tal Gonen, Yael Weiss-Ottolenghi, Sharon Amit, Ram Doolman, Ella Mendelson, Laurence S Freedman, Yitshak Kreiss, Yaniv Lustig, Gili Regev-Yochay
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose. The New England journal of medicine 387 (22) (2022)
Goldenfeld Miki, Carmit Cohen, Mayan Gilboa, Itai M Pessach, Bella Mehnick, Ilana Tal, Lilac Meltzer, Sharon Amit, Tal Gonen, Arnon Afek, Yitshak Kreiss, Gili Regev-Yochay
Rapid Antigen Tests For Safe School Opening in the COVID-19 Pandemic Era. The Pediatric infectious disease journal 41 (8) (2022)
Goldenfeld Miki, Neta Zuckerman, Sharon Amit, Ilana Tal, Sabrina Hasson, Shiraz Gefen-Halevi, Asaf Biber, Orna Mor, Gili Regev-Yochay
First Reported Nosocomial SARS-CoV-2 Outbreak in a Hospital-Based Laundry Facility. Epidemiology and infection (2021)
Hadar Rosen, Yossi Bart, Rita Zlatkin, Liat Ben-Sira, Dafna Ben Bashat, Sharon Amit, Carmit Cohen, Gili Regev-Yochay, Yoav Yinon
Fetal and Perinatal Outcome Following First and Second Trimester COVID-19 Infection: Evidence from a Prospective Cohort Study. Journal of clinical medicine 10 (10) (2021)
Yael Gozlan, Stephen Reingold, Ravit Koren, Osnat Halpern, Gili Regev-Yochay, Carmit Cohen, Asaf Biber, Orit Picard, Ella Mendelson, Yaniv Lustig, Orna Mor
SARS-CoV-2 outbreak in a synagogue community: longevity and strength of anti-SARS-CoV-2 IgG responses. Epidemiology and infection 149 (2021)
Rania Abu Seir, Kifaya Azmi, Ayob Hamdan, Hanan Namouz, Fuad Jaar, Hanaa Jaber, Carmit Rubin, Dafna Doron, Galia Rahav, Ziad Abdeen, Gili Regev-Yochay
Comparison of early effects of pneumococcal conjugate vaccines: PCV7, PCV10 and PCV13 on Streptococcus pneumoniae nasopharyngeal carriage in a population based study; The Palestinian-Israeli Collaborative Research (PICR). PloS one 13 (11) (2018)

Gili Regev-Yochay.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gili Regev-Yochay